# ANTERO RESOURCES Corp: financial statements, quarterly AR · NYSE · CIK 1433270 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ar.md) · [Financials](/companies/ar/financials.md) · [Filings](/companies/ar/filings.md) · [Insiders](/companies/ar/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ar/financials.md?period=annual). ## Income statement | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,194 d](/filings/0001104659-26-013386.md) | [1,122](/filings/0001558370-25-006004.md) | [979](/filings/0001558370-25-009802.md) | [1,056](/filings/0001104659-25-103735.md) | [1,169 d](/filings/0001104659-26-013386.md) | [1,353](/filings/0001104659-26-051530.md) | [1,297](/filings/0001104659-26-088153.md) | [1,214](/filings/0001104659-26-119637.md) | [1,412 d](/filings/0001104659-26-013386.md) | [1,945](/filings/0001104659-26-051530.md) | [1,560](/filings/0001104659-26-088153.md) | [1,563](/filings/0001104659-26-119637.md) | | Operating income | $m | [98.0 d](/filings/0001104659-26-013386.md) | [47.7](/filings/0001558370-25-006004.md) | [(80.1)](/filings/0001558370-25-009802.md) | [(25.0)](/filings/0001104659-25-103735.md) | [57.8 d](/filings/0001104659-26-013386.md) | [271](/filings/0001104659-26-051530.md) | [205](/filings/0001104659-26-088153.md) | [118](/filings/0001104659-26-119637.md) | [289 d](/filings/0001104659-26-013386.md) | [729](/filings/0001104659-26-051530.md) | [375](/filings/0001104659-26-088153.md) | [392](/filings/0001104659-26-119637.md) | | Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $m | [17.6 d](/filings/0001104659-26-013386.md) | [6.2](/filings/0001558370-25-006004.md) | [(17.3)](/filings/0001558370-25-009802.md) | [(3.0)](/filings/0001104659-25-103735.md) | [(104) d](/filings/0001104659-26-013386.md) | [54.4](/filings/0001104659-26-051530.md) | [48.2](/filings/0001104659-26-088153.md) | [43.3](/filings/0001104659-26-119637.md) | [69.9 d](/filings/0001104659-26-013386.md) | [146](/filings/0001104659-26-051530.md) | [79.0](/filings/0001104659-26-088153.md) | [96.4](/filings/0001104659-26-119637.md) | | Net income | $m | [71.4 d](/filings/0001104659-26-013386.md) | [34.7](/filings/0001104659-25-103735.md) | [(74.6)](/filings/0001104659-25-103735.md) | [(25.2)](/filings/0001104659-25-103735.md) | [159 d](/filings/0001104659-26-013386.md) | [219](/filings/0001104659-26-119637.md) | [167](/filings/0001104659-26-119637.md) | [85.6](/filings/0001104659-26-119637.md) | [203 d](/filings/0001104659-26-013386.md) | [548](/filings/0001104659-26-119637.md) | [286](/filings/0001104659-26-119637.md) | [367](/filings/0001104659-26-119637.md) | | Diluted EPS | $ per share | not reported | [0.07](/filings/0001558370-25-006004.md) | [(0.26)](/filings/0001558370-25-009802.md) | [(0.11)](/filings/0001104659-25-103735.md) | not reported | [0.66](/filings/0001104659-26-051530.md) | [0.50](/filings/0001104659-26-088153.md) | [0.24](/filings/0001104659-26-119637.md) | not reported | [1.72](/filings/0001104659-26-051530.md) | [0.90](/filings/0001104659-26-088153.md) | [1.19](/filings/0001104659-26-119637.md) | | Basic EPS | $ per share | not reported | [0.07](/filings/0001558370-25-006004.md) | [(0.26)](/filings/0001558370-25-009802.md) | [(0.11)](/filings/0001104659-25-103735.md) | not reported | [0.67](/filings/0001104659-26-051530.md) | [0.50](/filings/0001104659-26-088153.md) | [0.25](/filings/0001104659-26-119637.md) | not reported | [1.73](/filings/0001104659-26-051530.md) | [0.90](/filings/0001104659-26-088153.md) | [1.19](/filings/0001104659-26-119637.md) | - Revenue: us-gaap:Revenues - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:ProfitLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current assets | $bn | [0.5](/filings/0001558370-25-000864.md) | [0.4](/filings/0001558370-24-005602.md) | [0.4](/filings/0001558370-24-010482.md) | [0.4](/filings/0001558370-24-013956.md) | [0.5](/filings/0001104659-26-013386.md) | [0.6](/filings/0001558370-25-006004.md) | [0.4](/filings/0001558370-25-009802.md) | [0.4](/filings/0001104659-25-103735.md) | [0.8](/filings/0001104659-26-119637.md) | [0.7](/filings/0001104659-26-051530.md) | [0.7](/filings/0001104659-26-088153.md) | [0.8](/filings/0001104659-26-119637.md) | | Total assets | $bn | [13.5](/filings/0001558370-25-000864.md) | [13.5](/filings/0001558370-24-005602.md) | [13.4](/filings/0001558370-24-010482.md) | [13.2](/filings/0001558370-24-013956.md) | [13.0](/filings/0001104659-26-013386.md) | [13.0](/filings/0001558370-25-006004.md) | [12.8](/filings/0001558370-25-009802.md) | [12.9](/filings/0001104659-25-103735.md) | [13.2](/filings/0001104659-26-119637.md) | [15.3](/filings/0001104659-26-051530.md) | [15.2](/filings/0001104659-26-088153.md) | [15.6](/filings/0001104659-26-119637.md) | | Current liabilities | $bn | [1.5](/filings/0001558370-25-000864.md) | [1.4](/filings/0001558370-24-005602.md) | [1.4](/filings/0001558370-24-010482.md) | [1.3](/filings/0001558370-24-013956.md) | [1.4](/filings/0001104659-26-013386.md) | [1.5](/filings/0001558370-25-006004.md) | [1.4](/filings/0001558370-25-009802.md) | [1.4](/filings/0001104659-25-103735.md) | [1.5](/filings/0001104659-26-119637.md) | [1.7](/filings/0001104659-26-051530.md) | [1.7](/filings/0001104659-26-088153.md) | [1.9](/filings/0001104659-26-119637.md) | | Total liabilities | $bn | [6.4](/filings/0001558370-25-000864.md) | [6.3](/filings/0001558370-24-005602.md) | [6.2](/filings/0001558370-24-010482.md) | [6.0](/filings/0001558370-24-013956.md) | [5.8](/filings/0001104659-26-013386.md) | [5.6](/filings/0001558370-25-006004.md) | [5.3](/filings/0001558370-25-009802.md) | [5.4](/filings/0001104659-25-103735.md) | [5.5](/filings/0001104659-26-119637.md) | [7.1](/filings/0001104659-26-051530.md) | [6.9](/filings/0001104659-26-088153.md) | [6.9](/filings/0001104659-26-119637.md) | | Long-term debt | $bn | [1.5](/filings/0001558370-25-000864.md) | [1.5](/filings/0001558370-24-005602.md) | [1.6](/filings/0001558370-24-010482.md) | [1.6](/filings/0001558370-24-013956.md) | [1.5](/filings/0001104659-26-013386.md) | [1.3](/filings/0001558370-25-006004.md) | [1.1](/filings/0001558370-25-009802.md) | [1.3](/filings/0001104659-25-103735.md) | [1.4](/filings/0001104659-26-119637.md) | [2.7](/filings/0001104659-26-051530.md) | [2.4](/filings/0001104659-26-088153.md) | [2.3](/filings/0001104659-26-119637.md) | | Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.2](/filings/0001104659-26-088153.md) | [0.5](/filings/0001104659-26-119637.md) | | Shareholders' equity | $bn | [6.9](/filings/0001558370-25-000864.md) | [7.1](/filings/0001558370-24-005602.md) | [7.0](/filings/0001558370-24-010482.md) | [7.0](/filings/0001558370-24-013956.md) | [7.0](/filings/0001104659-26-013386.md) | [7.2](/filings/0001558370-25-006004.md) | [7.3](/filings/0001558370-25-009802.md) | [7.3](/filings/0001104659-25-103735.md) | [7.6](/filings/0001104659-26-119637.md) | [8.1](/filings/0001104659-26-051530.md) | [8.3](/filings/0001104659-26-088153.md) | [8.6](/filings/0001104659-26-119637.md) | - Cash and equivalents: not reported - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Short-term borrowings: us-gaap:CommercialPaper - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [312 d](/filings/0001104659-26-013386.md) | [262](/filings/0001558370-25-006004.md) | [143 d](/filings/0001558370-25-009802.md) | [166 d](/filings/0001104659-25-103735.md) | [278 d](/filings/0001104659-26-013386.md) | [458](/filings/0001104659-26-051530.md) | [492 d](/filings/0001104659-26-088153.md) | [310 d](/filings/0001104659-26-119637.md) | [371 d](/filings/0001104659-26-013386.md) | [859](/filings/0001104659-26-051530.md) | [439 d](/filings/0001104659-26-088153.md) | [575 d](/filings/0001104659-26-119637.md) | | Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $m | [(0.0) d](/filings/0001104659-26-013386.md) | not reported | not reported | not reported | not reported | [10.1](/filings/0001104659-26-051530.md) | [74.9 d](/filings/0001104659-26-088153.md) | [51.4 d](/filings/0001104659-26-119637.md) | [0.1 d](/filings/0001104659-26-013386.md) | not reported | not reported | [55.7 d](/filings/0001104659-26-119637.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: not reported - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [312](/filings/0001558370-24-005602.md) | [300](/filings/0001558370-24-010482.md) | [312](/filings/0001558370-24-013956.md) | [313](/filings/0001558370-25-006004.md) | [311](/filings/0001558370-25-009802.md) | [311](/filings/0001104659-25-103735.md) | [315](/filings/0001104659-26-051530.md) | [313](/filings/0001104659-26-088153.md) | [311](/filings/0001104659-26-119637.md) | [311](/filings/0001104659-26-051530.md) | [311](/filings/0001104659-26-088153.md) | [309](/filings/0001104659-26-119637.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 307,136,000 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001104659-26-119637.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 05:24 ET. No prices; not investment advice.